Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults

Published:2017-05-26 Issue:12 Volume:215 Page:1789-1798
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Halperin Scott A.¹,Arribas Jose R.²,Rupp Richard³,Andrews Charles P.⁴,Chu Laurence⁵,Das Rituparna⁶,Simon Jakub K.⁶,Onorato Matthew T.⁶,Liu Kenneth⁶,Martin Jason⁶,Helmond Frans A.⁶,

Affiliation:

1. Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, Canada;

2. Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; and

3. University of Texas Medical Branch at Galveston,

4. Diagnostics Research Group, San Antonio,

5. Benchmark Research, Austin, Texas, and

6. Merck & Co, Inc, Kenilworth, New Jersey

Funder

Canadian Institutes of Health Research

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/215/12/1789/24262177/jix189.pdf

Reference13 articles.

1. After Ebola in West Africa—unpredictable risks, preventable epidemics;World Health Organization Ebola Response Team;N Engl J Med,2016

2. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases;Tully;Lancet Infect Dis,2015

3. Human infection with the virus of vesicular stomatitis during an epizootic;Fields;N Engl J Med,1967

4. A recombinant vesicular stomatitis virus Ebola vaccine;Regules;N Engl J Med,2017

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America;Frontiers in Immunology;2024-01-03

2. Nanoparticles and Antiviral Vaccines;Vaccines;2023-12-27

3. Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Vaccines;2023-12-22

4. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials;Vaccine;2022-11

5. Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines;Vaccines;2022-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3